Trends in multidrug-resistant tuberculosis
AUTOR(ES)
Dias-Baptista, I. M. F., Usó, S. M. R. S., Marcondes-Machado, J.
FONTE
Journal of Venomous Animals and Toxins including Tropical Diseases
DATA DE PUBLICAÇÃO
2008
RESUMO
Multidrug-resistant tuberculosis (MDR-TB) is an increasing global problem. The extent and burden of MDR-TB varies significantly from country to country and region to region. Globally, about three per cent of all newly diagnosed patients have MDR-TB and the proportion is higher in patients who had previously received anti-tuberculosis (anti-TB) treatment reflecting the failure of programs designed to ensure complete cure of patients with tuberculosis. The management of MDR-TB is a challenge that should be undertaken by experienced clinicians at centers equipped with reliable laboratory services and implementation of DOTS-Plus strategy.
Documentos Relacionados
- Multidrug-resistant tuberculosis
- Role of surgery in pulmonary multidrug‐resistant tuberculosis
- Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis
- Predictive model of unfavorable outcomes for multidrug-resistant tuberculosis
- The importance of audiometric monitoring in patients with multidrug-resistant tuberculosis
